Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
5,13 Vildagliptin is recommended at Step 2 for people with type 2 diabetes who are not eligible for funded SGLT-2 inhibitor or GLP-1 receptor agonist treatment (also see: Clinical scenarios where empagliflozin or dulaglutide are recommended, but not funded)
Cheng, M
FDA-Approved GLP-1 Drugs Expected Annual Health Plan Costs for a 250-Life Employer Group Source:[10] Berkley Accident and Health Internal Data While it remains to be seen exactly how insurers will manage these rising costs, we estimate that an employer with 250 covered employees will spend between $60,000-$112,000 on GLP-1s alone in 2025
These smaller syringes have finer graduation marks, making it easier to measure very small doses accurately
US$ 29.64
US$ 21.96
US$ 28.74
US$ 20.78
